Cochrane Abstracts
Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Palivizumab for Prophylaxis Against Respiratory Syncytial Virus Infection in Children With Cystic Fibrosis." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431470/all/Palivizumab_for_prophylaxis_against_respiratory_syncytial_virus_infection_in_children_with_cystic_fibrosis.
Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431470/all/Palivizumab_for_prophylaxis_against_respiratory_syncytial_virus_infection_in_children_with_cystic_fibrosis. Accessed December 8, 2024.
Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431470/all/Palivizumab_for_prophylaxis_against_respiratory_syncytial_virus_infection_in_children_with_cystic_fibrosis
Palivizumab for Prophylaxis Against Respiratory Syncytial Virus Infection in Children With Cystic Fibrosis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431470/all/Palivizumab_for_prophylaxis_against_respiratory_syncytial_virus_infection_in_children_with_cystic_fibrosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis
ID - 431470
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431470/all/Palivizumab_for_prophylaxis_against_respiratory_syncytial_virus_infection_in_children_with_cystic_fibrosis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
